Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102333 trials found · Page 170 of 5117
-
Stoma fluid recycling may stop post-surgery bowel chaos
Prevention Recruiting nowThe goal of this clinical trial is to learn if antegrade intestinal fluid reinfusion works to prevent low anterior resection syndrome (LARS) in patients with prophylactic ileal stoma. The main questions it aims to answer are: 1. Does it work to prevent LARS by antegrade intestin…
Phase: PHASE2, PHASE3 • Sponsor: Pei-Rong Ding • Aim: Prevention
Last updated Jun 10, 2026 08:40 UTC
-
New combo therapy offers hope for Hard-to-Treat throat cancer
Disease control Not yet recruitingThe investigators plan to conduct a multicenter, prospective, single-arm phase II clinical trial of PD-1 monoclonal antibody combined with gemcitabine and cisplatin followed by selective radiotherapy for unresectable locally recurrent nasopharyngeal carcinoma to evaluate the effi…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug combo aims to shrink advanced cervical tumors
Disease control Not yet recruitingThis is a single-arm, multicenter, phase II study designed to evaluate the efficacy and safety of MRG003, an anti-EGFR antibody-drug conjugate, in combination with QL1706, a PD-1/CTLA-4 bispecific antibody, in patients with recurrent or metastatic cervical cancer who have failed …
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
New hope for hard-to-treat lung cancer: drug combo trial opens
Disease control Recruiting nowThe researchers are doing this study to find out whether ivonescimab in combination with datopotamab deruxtecan- (Dato-DXd) or osimertinib are safe and effective treatments in people with non-small cell lung cancer (NSCLC) that has an EGFR mutation. The researchers will test diff…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New triple therapy aims to shrink tough colorectal tumors before surgery
Disease control Recruiting nowThis is an open-label, multicenter, phase Ib/II combined trial of sitagliptin, XELOX chemotherapy regimen, and PD-1 monoclonal antibody in the treatment of proficient mismatch repair locally advanced colorectal cancer.
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
New app aims to boost HIV prevention in women facing violence and addiction
Prevention Recruiting now(Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month fo…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 09, 2026 12:10 UTC
-
New dengue drug trial aims to shorten illness and lower virus levels
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled Phase 2/3 study to evaluate the efficacy, safety, and antiviral activity of CP-COV03 in adult patients with dengue infection.
Phase: PHASE2, PHASE3 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 10, 2026 08:44 UTC
-
New combo therapy aims to extend life in advanced kidney cancer
Disease control Recruiting nowResearchers are looking for new ways to treat advanced renal cell carcinoma (RCC). A standard (usual) treatment for certain people with RCC is belzutifan (a study medicine), which is a targeted therapy. Targeted therapy is a treatment that works to control how specific types of …
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
Brain implant tweak could ease Parkinson's symptoms around the clock
Symptom relief Recruiting nowThe purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect us…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 08, 2026 13:17 UTC
-
New drug combo aims to boost platelets in ITP patients
Disease control Recruiting nowThis is a randomized controlled study of high-dose Dexamethasone combined with Orelabrutinib versus high-dose Dexamethasone combined with placebo in adult patients with newly diagnosed Primary Immune Thrombocytopenia.
Phase: PHASE3 • Sponsor: Shandong University • Aim: Disease control
Last updated Jun 10, 2026 08:44 UTC
-
Lyme vaccine boost: pfizer tests fifth shot for Long-Term protection
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this study is to learn about the safety effects of the Lyme disease vaccine (called VLA15), and its ability to protect people from Lyme disease after a 5th dose of the vaccine. This study is seeking participants who: * are generally healthy and 7 years of age and…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 05, 2026 12:08 UTC
-
Blood tests may guide better lung cancer treatment choices
Knowledge-focused Recruiting nowThis phase II trial tests the impact of biomarkers in predicting initial treatment (first-line) PD1 or PD-L1 (PD\[L\]-1)-based immunotherapy response and in selecting second-line treatment in patients with stage IIIB-IV non-small cell lung cancer (NSCLC). Response and survival ra…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:08 UTC
-
Women's heart failure: quick drug boost may save lives
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether a rapid and intensive optimization of heart failure medications in women can improve outcomes after hospitalization for heart failure. It will also investigate the safety and the tolerance of these treatments when given at full …
Phase: PHASE4 • Sponsor: IRCCS Policlinico S. Donato • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC
-
New combo therapy aims to control prostate cancer
Disease control Recruiting nowThe study aims to assess the safety and tolerability of SHR-4394 in combination with anti-tumor therapy in participants with prostate cancer, and determine the recommended Phase II dose (RP2D); To evaluate of the efficacy of SHR-4394 in combination with anti-tumor therapy in part…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
New ALS drug trial hopes to slow Disease's deadly march
Disease control Not yet recruitingFIH, Phase 1/2, multi-centre, randomised, double-blind, placebo controlled study with an optional open-label dosing extension to assess the safety, tolerability, efficacy, and Pharmacodynamics (PD) of single or multiple (up to 48 weeks QD) subcutaneous (SC) doses of PLL001 compar…
Phase: PHASE1, PHASE2 • Sponsor: PLL TX AUSTRALIA PTY LTD • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
ERs could be front line against HIV: new study offers pills on the spot
Prevention Recruiting nowOur primary objective is to increase HIV pre-exposure prophylaxis (PrEP) awareness and uptake among people who want, need, or would benefit from PrEP in Dallas, TX through a pilot program of immediate PrEP prescribing in the Parkland Memorial Hospital Emergency Department (ED) wi…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 09, 2026 12:06 UTC
-
Freezing out tumors: could cryoablation replace surgery for early breast cancer?
Disease control Recruiting nowLUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women
Phase: NA • Sponsor: Lucía Graña López • Aim: Disease control
Last updated Jun 09, 2026 12:14 UTC
-
New shot could shrink HIV-Linked skin cancer tumors
Disease control Recruiting nowBackground: Kaposi sarcoma (KS) is a cancer that causes abnormal tissue to grow in the skin, lymph nodes, and other organs. KS is caused by a virus known as Kaposi sarcoma herpesvirus. People infected with human immunodeficiency virus (HIV) account for 80% of KS cases in the Uni…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 27, 2026 12:02 UTC
-
Mobile clinics and peer support aim to curb opioid crisis in rural communities
Disease control Recruiting nowThis study will provide longitudinal data for 6-months on a target sample of patients with Opioid Use Disorder (OUD) recruited from Prisma Health Mobile Health Clinics in South Carolina. The goal of our study is to increase OUD treatment initiation and retention and maximize prev…
Phase: NA • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 01, 2026 18:03 UTC
-
New stroke drug shows promise in early trial
Disease control Recruiting nowAcute ischemic stroke (AIS) is a medical emergency that happens because of a sudden stop of blood flow to a part of the brain. This happens when a blood clot forms within the vessel (known as thrombotic occlusion) or a clot originating from somewhere else blocks a blood vessel (k…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC